Ascendis Pharma · 4 months ago
Regional Sales Director, Rare Conditions (Central) - Job ID: 1710
Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company focused on advancing programs in Endocrinology, Rare Disease, and Oncology. They are seeking a highly motivated and experienced Regional Sales Director to lead a team of Rare Conditions Clinical Specialists and a Rare Conditions Account Manager, fostering a culture of winning through effective recruitment, coaching, and strategic decision-making.
BiotechnologyClinical TrialsHealth Care
Responsibilities
The RSD will establish and inspect clear and rigorous business fundamentals, behaviors and metrics, set high performance standards and meet or exceed sales goals across the business
The RSD will create immediate impact by successfully hiring, leading, coaching and motivating the high-performance sales team
RSDs are expected to adapt quickly to needs/adjustments necessitated by launch preparations and contribute to supporting both corporate and field-based colleagues in navigating a dynamic and evolving market to achieve and exceed expected results in a complex specialty environment
Coaching ECSs in line with Ascendis Pharma’s sales model to drive sustained improvement in core sales competencies; this includes clinical, product, business acumen as well as reimbursement skillsets. Routinely participate in Sales field rides, face to face customer meetings, target planning, territory alignment and develop employees based on observed knowledge, skill & behavior opportunities
Contribute to the development of the National Sales plan that aligns to organizational goals, leveraging analysis and interpretation of general economic, industry, marketing and sales data
Ensures the timely and accurate completion of all territory and regional level administrative tasks, including expense reporting, program funding requests and management communications
Qualification
Required
Ability to travel within the Region on a frequent overnight basis, with occasional weekend travel, depending on territory needs; 80% travel will be required
Location within assigned geography; access to a major airport is needed
Experience in leading a team consisting of Rare Conditions Clinical Specialists and a Rare Conditions Account Manager
Ability to foster a culture of winning through effective recruitment & hiring, coaching & development, collaboration across the organization, strategic decision making, and timely performance management
Ability to develop strong, collaborative partnerships with internal stakeholders in Marketing, Market Access, Medical Affairs, Commercial Operations, Patient services, Human Resources & Training
Establish and inspect clear and rigorous business fundamentals, behaviors and metrics, set high performance standards and meet or exceed sales goals across the business
Create immediate impact by successfully hiring, leading, coaching and motivating the high-performance sales team
Adapt quickly to needs/adjustments necessitated by launch preparations and contribute to supporting both corporate and field-based colleagues in navigating a dynamic and evolving market
Coach ECSs in line with Ascendis Pharma's sales model to drive sustained improvement in core sales competencies
Participate in Sales field rides, face to face customer meetings, target planning, territory alignment and develop employees based on observed knowledge, skill & behavior opportunities
Contribute to the development of the National Sales plan that aligns to organizational goals, leveraging analysis and interpretation of general economic, industry, marketing and sales data
Ensure the timely and accurate completion of all territory and regional level administrative tasks, including expense reporting, program funding requests and management communications
Company
Ascendis Pharma
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
Funding
Current Stage
Public CompanyTotal Funding
$1.88BKey Investors
Royalty Pharma
2024-09-19Post Ipo Equity· $300M
2024-09-03Post Ipo Debt· $150M
2023-09-05Post Ipo Debt· $150M
Leadership Team
Recent News
2026-01-11
2026-01-11
Company data provided by crunchbase